Castle Biosciences, Inc.CSTLNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.95
↓ 75% below average
Average (7y)
7.66
Historical baseline
Range
High:16.49
Low:1.95
CAGR
-26.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.95 | -13.5% |
| 2023 | 2.25 | -38.7% |
| 2022 | 3.68 | -54.3% |
| 2021 | 8.04 | -41.5% |
| 2020 | 13.75 | +222.2% |
| 2019 | 4.27 | -60.8% |
| 2018 | 10.88 | -34.0% |
| 2017 | 16.49 | - |